$TWST
Twist Bioscience Corp

2020 Q4 Form 10-K Financial Statement

#000119312520303904 Filed on November 27, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2019 Q3 2018 Q3
Revenue $28.16M $15.74M $8.410M
YoY Change 64.07% 87.16% 142.36%
Cost Of Revenue $18.16M $12.39M $9.090M
YoY Change 31.69% 36.3% 33.09%
Gross Profit $9.999M $3.350M -$690.0K
YoY Change 196.53% -585.51% -79.46%
Gross Profit Margin 35.51% 21.28% -8.2%
Selling, General & Admin $28.79M $24.42M $12.95M
YoY Change 9.04% 88.57% 53.98%
% of Gross Profit 287.95% 728.96%
Research & Development $14.00M $10.50M $6.070M
YoY Change 35.96% 72.98% 25.15%
% of Gross Profit 140.01% 313.43%
Depreciation & Amortization $2.111M $1.490M $1.330M
YoY Change 40.27% 12.03% 6.4%
% of Gross Profit 21.11% 44.48%
Operating Expenses $42.79M $34.92M $19.02M
YoY Change 16.59% 83.6% 43.44%
Operating Profit -$32.79M -$31.57M -$19.71M
YoY Change -41.26% 60.17% 18.59%
Interest Expense $118.0K $500.0K $20.00K
YoY Change -52.42% 2400.0% -133.33%
% of Operating Profit
Other Income/Expense, Net -$77.00K $0.00 -$50.00K
YoY Change -11.49% -100.0% -76.19%
Pretax Income -$32.85M -$31.07M -$19.73M
YoY Change -40.91% 57.48% 16.81%
Income Tax $46.00K $110.0K $80.00K
% Of Pretax Income
Net Earnings -$32.90M -$31.18M -$19.80M
YoY Change -40.87% 57.47% 16.4%
Net Earnings / Revenue -116.83% -198.09% -235.43%
Basic Earnings Per Share
Diluted Earnings Per Share -$715.2K -$960.0K -$744.1K
COMMON SHARES
Basic Shares Outstanding 45.15M 32.56M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $587.3M $138.1M $80.80M
YoY Change 469.64% 70.92%
Cash & Equivalents $350.3M $46.74M $80.76M
Short-Term Investments $238.5M $91.40M $0.00
Other Short-Term Assets $8.200M $2.600M $3.500M
YoY Change 43.86% -25.71%
Inventory $13.40M $7.330M $6.028M
Prepaid Expenses
Receivables $23.20M $12.10M $5.419M
Other Receivables $2.300M $0.00 $0.00
Total Short-Term Assets $634.4M $160.1M $95.67M
YoY Change 390.69% 67.38%
LONG-TERM ASSETS
Property, Plant & Equipment $59.50M $20.84M $12.33M
YoY Change 178.83% 68.96%
Goodwill $1.138M $1.138M
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.300M $3.799M $5.360M
YoY Change 92.22% -29.12%
Total Long-Term Assets $65.20M $26.86M $20.12M
YoY Change 3.51% 33.49%
TOTAL ASSETS
Total Short-Term Assets $634.4M $160.1M $95.67M
Total Long-Term Assets $65.20M $26.86M $20.12M
Total Assets $699.6M $187.0M $115.8M
YoY Change 263.85% 61.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.900M $9.760M $7.531M
YoY Change -2.26% 29.6%
Accrued Expenses $21.50M $5.965M $2.166M
YoY Change 358.72% 175.39%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.300M $3.333M $2.500M
YoY Change -0.99% 33.32%
Total Short-Term Liabilities $37.10M $30.35M $18.54M
YoY Change -35.86% 63.75%
LONG-TERM LIABILITIES
Long-Term Debt $600.0K $4.400M $7.218M
YoY Change -83.65% -39.04%
Other Long-Term Liabilities $23.90M $158.0K $344.0K
YoY Change 16497.22% -54.07%
Total Long-Term Liabilities $24.50M $4.558M $7.562M
YoY Change 542.54% -39.72%
TOTAL LIABILITIES
Total Short-Term Liabilities $37.10M $30.35M $18.54M
Total Long-Term Liabilities $24.50M $4.558M $7.562M
Total Liabilities $61.60M $34.91M $26.73M
YoY Change -30.94% 30.61%
SHAREHOLDERS EQUITY
Retained Earnings -$318.5M -$210.9M
YoY Change 51.06%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $638.0M $152.1M -$201.4M
YoY Change
Total Liabilities & Shareholders Equity $699.6M $187.0M $115.8M
YoY Change 263.85% 61.49%

Cashflow Statement

Concept 2020 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income -$32.90M -$31.18M -$19.80M
YoY Change -40.87% 57.47% 16.4%
Depreciation, Depletion And Amortization $2.111M $1.490M $1.330M
YoY Change 40.27% 12.03% 6.4%
Cash From Operating Activities -$24.93M -$23.36M -$16.69M
YoY Change -28.59% 39.96% 45.64%
INVESTING ACTIVITIES
Capital Expenditures $3.629M -$3.900M -$1.050M
YoY Change 76.34% 271.43% -68.47%
Acquisitions
YoY Change
Other Investing Activities -$42.29M $2.710M $1.450M
YoY Change -392.46% 86.9% -113.04%
Cash From Investing Activities -$45.92M -$1.190M $410.0K
YoY Change -470.18% -390.24% -102.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 326.9M 2.930M 6.580M
YoY Change 15793.1% -55.47% 520.75%
NET CHANGE
Cash From Operating Activities -24.93M -23.36M -16.69M
Cash From Investing Activities -45.92M -1.190M 410.0K
Cash From Financing Activities 326.9M 2.930M 6.580M
Net Change In Cash 256.1M -21.62M -9.700M
YoY Change -1352.62% 122.89% -60.97%
FREE CASH FLOW
Cash From Operating Activities -$24.93M -$23.36M -$16.69M
Capital Expenditures $3.629M -$3.900M -$1.050M
Free Cash Flow -$28.56M -$19.46M -$15.64M
YoY Change -22.75% 24.42% 92.37%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25466000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20835000
CY2020Q3 us-gaap Goodwill
Goodwill
1138000
CY2019Q3 us-gaap Goodwill
Goodwill
1138000
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2823000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3799000
CY2020Q3 us-gaap Assets
Assets
398882000
CY2019Q3 us-gaap Assets
Assets
186994000
CY2020Q3 us-gaap Short Term Investments
ShortTermInvestments
196335000
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26376000
CY2019Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
12104000
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6203000
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2594000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
334870000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
160135000
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1403000
CY2019Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
4400000
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
351000
CY2019Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
158000
CY2020Q3 us-gaap Liabilities
Liabilities
62620000
CY2019Q3 us-gaap Liabilities
Liabilities
34912000
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4830000
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9760000
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3901000
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5965000
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3333000
CY2019Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3333000
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2611000
CY2019Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
817000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
36029000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
30354000
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
794630000
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
470425000
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
87000
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
181000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-458455000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-318524000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
336262000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
152082000
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
398882000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
186994000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
61406000
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
47426000
CY2018 us-gaap Cost Of Revenue
CostOfRevenue
32189000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-34000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-60000
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
45000
CY2018 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
54000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-140025000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-107575000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-71182000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
43006000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35683000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20347000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
103267000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
80126000
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
43450000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
230179000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
163235000
CY2018 us-gaap Costs And Expenses
CostsAndExpenses
95986000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-140079000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-108850000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-70559000
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
1499000
CY2019 us-gaap Investment Income Interest
InvestmentIncomeInterest
3032000
CY2018 us-gaap Investment Income Interest
InvestmentIncomeInterest
999000
CY2020 us-gaap Interest Expense
InterestExpense
787000
CY2019 us-gaap Interest Expense
InterestExpense
1294000
CY2018 us-gaap Interest Expense
InterestExpense
1313000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-182000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-265000
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-121000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-139549000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-107377000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-70994000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
382000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
292000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
242000
CY2019Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
-133358000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
215000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2961000
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
54000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-201422000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2264000
CY2019 twst Stock Issued During Period Value Conversion Of Convertible Warrant
StockIssuedDuringPeriodValueConversionOfConvertibleWarrant
631000
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
290462000
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2064000
CY2018 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
812000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11170000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
94000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
295563000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10539000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17096000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-94000
CY2019 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2700000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6677000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6111000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5727000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-189000
CY2018 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-55000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
17096000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
11170000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
2961000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
214000
CY2020 us-gaap Other Noncash Expense
OtherNoncashExpense
152000
CY2019 us-gaap Other Noncash Expense
OtherNoncashExpense
233000
CY2018 us-gaap Other Noncash Expense
OtherNoncashExpense
254000
CY2018 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-13000
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
184000
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
282000
CY2018 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
308000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14272000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6685000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3073000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4956000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1302000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4202000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3683000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-746000
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1760000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
554000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5506000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3278000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3759000
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-2648000
CY2019 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4210000
CY2018 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-114000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4465000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
5060000
CY2018 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1932000
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1978000
CY2019 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-247000
CY2018 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
50000
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
10495000
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
2170000
CY2018 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
331000
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
295563000
CY2018 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
90850000
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3333000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
303732000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
158578000
CY2020 us-gaap Profit Loss
ProfitLoss
-139931000
CY2019 us-gaap Profit Loss
ProfitLoss
-107669000
CY2018 us-gaap Profit Loss
ProfitLoss
-71236000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-142255000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-87937000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-66164000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9868000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14757000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3688000
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
21000
CY2018 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
17000
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
202882000
CY2019 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
177574000
CY2018 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3523000
CY2020 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
98100000
CY2019 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
87500000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81537000
CY2020Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
290002000
CY2019Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
138107000
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
9237000
CY2019Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
4900000
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
2021000
CY2019Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1157000
CY2018 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
34500000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-114650000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-104810000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
27306000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
88822000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
46848000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-34139000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
49964000
CY2017Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31573000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
438000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
779000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
751000
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
172000
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
291000
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
179000
CY2020 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
1333000
CY2019 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
170000
CY2018 us-gaap Liabilities Assumed1
LiabilitiesAssumed1
344000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
93667000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46735000
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80757000
CY2020Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
579000
CY2019Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
579000
CY2018Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
579000
CY2019Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
84000
CY2018Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
201000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94246000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47398000
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1031000
CY2019Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1273000
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1240000
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
933000
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
307000
CY2019Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1240000
CY2019Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
732000
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
508000
CY2020 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
3400000
CY2018Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
68901000
CY2018Q4 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
57122000
CY2019Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
32064000
CY2019Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
6.24
CY2019Q3 twst Net Exercise Of Common Stock Warrants Shares
NetExerciseOfCommonStockWarrantsShares
25422000
CY2020Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
951000
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
42400000
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17096000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11170000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2961000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-139931000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-107669000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-71236000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
39190
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27462
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2793
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.57
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.92
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-25.51
CY2018 twst Treasury Stock Repurchased During Period Value
TreasuryStockRepurchasedDuringPeriodValue
-58000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
153852000
CY2019 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
0
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3428000
CY2020 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
3428000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21000
CY2020 twst Credit Period Granted To Customers
CreditPeriodGrantedToCustomers
P30D
CY2020Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
2400
CY2019Q3 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
2300
CY2020 us-gaap Advertising Expense
AdvertisingExpense
1200
CY2019 us-gaap Advertising Expense
AdvertisingExpense
1300
CY2018 us-gaap Advertising Expense
AdvertisingExpense
900
CY2020Q3 twst Cash And Cash Equivalents At Amortized Cost
CashAndCashEquivalentsAtAmortizedCost
93667000
CY2020Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
196320000
CY2020 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
15000
CY2020 twst Availableforsale Securities Gross Unrealized Gain Loss
AvailableforsaleSecuritiesGrossUnrealizedGainLoss
15000
CY2019Q3 twst Cash And Cash Equivalents At Amortized Cost
CashAndCashEquivalentsAtAmortizedCost
46735000
CY2020Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
25790000
CY2019Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
11085000
CY2019Q3 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
1313000
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
365000
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
294000
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
54944000
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
43828000
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29478000
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
22993000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
204000
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
103000
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
3333000
CY2020Q3 twst Long Term Debt Maturities Interest Payable In Year Two
LongTermDebtMaturitiesInterestPayableInYearTwo
-167000
CY2020Q3 twst Long Term Debt Maturities Repayment Principal And Interest In Year Two
LongTermDebtMaturitiesRepaymentPrincipalAndInterestInYearTwo
3500000
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
833000
CY2020Q3 twst Long Term Debt Maturities Interest Payable In Year Three
LongTermDebtMaturitiesInterestPayableInYearThree
-9000
CY2020Q3 twst Long Term Debt Maturities Repayment Principal And Interest In Year Three
LongTermDebtMaturitiesRepaymentPrincipalAndInterestInYearThree
842000
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
4166000
CY2020Q3 twst Interest Payable On Long Term Debt
InterestPayableOnLongTermDebt
-176000
CY2020Q3 twst Long Term Debt Maturities Repayment Principal And Interesttotal
LongTermDebtMaturitiesRepaymentPrincipalAndInteresttotal
4342000
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
127336000
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
4166000
CY2020Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
85000
CY2020Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
5639000
CY2019Q3 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
4553000
CY2020Q3 twst Accretion Of Final Payment Fee
AccretionOfFinalPaymentFee
655000
CY2020Q3 twst Long Term Debt Including Interest And Fee Payable
LongTermDebtIncludingInterestAndFeePayable
4736000
CY2020Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
112434000
CY2019Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
73341000
CY2020Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
9407000
CY2020Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
134986000
CY2019Q3 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
84725000
CY2019Q3 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
6831000
CY2019Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
84598000
CY2020Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
7650000
CY2019Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
127000
CY2020Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
105000
CY2019Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
1000
CY2020Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
47000
CY2019Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
126000
CY2020Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
7650000
CY2019Q3 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
127000
CY2017Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1625000
CY2018 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
624000
CY2018Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2249000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1042000
CY2019Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
3291000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1409000
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4700000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M12D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y4M24D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.621
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.602
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.663
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.013
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.027
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.027
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
20.76
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
15.06
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.08
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.25
CY2020Q3 twst Sharebased Compensation Arrangement By Sharebased Payment Award Right Of Repurchase
SharebasedCompensationArrangementBySharebasedPaymentAwardRightOfRepurchase
16815
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4593
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4177
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21786
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
90100000
CY2019 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
54385000
CY2018 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
25427000
CY2019Q3 us-gaap Short Term Investments
ShortTermInvestments
91372000
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14945000
CY2019Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10479000
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33699000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6409000
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24837000
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32873000
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45083000
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45083000
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32873000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
49000
CY2020 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
22500000
CY2020Q3 us-gaap Inventory Net
InventoryNet
12289000
CY2019Q3 us-gaap Inventory Net
InventoryNet
7330000
CY2019 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2020 us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
CY2020 us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
-2421000
CY2019 twst Underwriting Discounts Commissions And Offering Expenses
UnderwritingDiscountsCommissionsAndOfferingExpenses
17210000
CY2020 twst Underwriting Discounts Commissions And Offering Expenses
UnderwritingDiscountsCommissionsAndOfferingExpenses
18916000
CY2020 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
-1043000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1249000
CY2019 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
156208000
CY2019 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2700000
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2359000
CY2019 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2500000
CY2020 twst Payments To Repurchases Of Common Stock For Tax Withholding
PaymentsToRepurchasesOfCommonStockForTaxWithholding
2421000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3718000
CY2018 us-gaap Noncash Or Part Noncash Acquisition Payables Assumed1
NoncashOrPartNoncashAcquisitionPayablesAssumed1
1308000
CY2019 twst Conversion Of Convertible Preferred Stock Warrant
ConversionOfConvertiblePreferredStockWarrant
631000
CY2019 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
290462000
CY2019Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
91323000
CY2019 us-gaap Available For Sale Securities Gross Unrealized Gains
AvailableForSaleSecuritiesGrossUnrealizedGains
49000
CY2019 twst Availableforsale Securities Gross Unrealized Gain Loss
AvailableforsaleSecuritiesGrossUnrealizedGainLoss
49000
CY2019Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
16221000
CY2019Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
7.84
CY2019Q3 twst Net Exercise Of Common Stock Warrants Shares
NetExerciseOfCommonStockWarrantsShares
12019000
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 18pt; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Concentration of credit risk </div></div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 6pt; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents, short-term investments and accounts receivable. Substantially all of the Company&#8217;s cash is held by one financial institution that management believes is of high credit quality. Such deposits may, at times, exceed federally insured limits. The Company&#8217;s investment policy addresses the level of credit exposure by establishing a minimum allowable credit rating and by limiting the concentration in any one investment. </div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 12pt; margin-right: 0px; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company&#8217;s accounts receivable is derived from customers located principally in the United States and Europe. The Company maintains credit insurance for certain of its customer balances, performs ongoing credit evaluations of its customers, and maintains allowances for potential credit losses on customers&#8217; accounts when deemed necessary. The Company does not typically require collateral from its customers. Credit losses historically have not been material. The Company continuously monitors customer payments and maintains an allowance for doubtful accounts based on its assessment of various factors including historical experience, age of the receivable balances, and other current economic conditions or other factors that may affect customers&#8217; ability to pay. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001581280
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2020 dei Entity Small Business
EntitySmallBusiness
false
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020 dei Security12b Title
Security12bTitle
Common Stock
CY2020 dei Trading Symbol
TradingSymbol
TWST
CY2020Q1 dei Entity Public Float
EntityPublicFloat
1088000000
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2019 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2018 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2020Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2019Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2019Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2017 twst Contract Payments Research And Development Received
ContractPaymentsResearchAndDevelopmentReceived
0
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020 us-gaap Line Of Credit Facility Collateral Fees Amount
LineOfCreditFacilityCollateralFeesAmount
100000
CY2020Q3 us-gaap Deferred Tax Liabilities Leasing Arrangements
DeferredTaxLiabilitiesLeasingArrangements
7498000
CY2020Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
200000
CY2020Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2019Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2020 twst Tax Credit
TaxCredit
2033
CY2020Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
26385000
CY2020Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
18854000
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Registrant Name
EntityRegistrantName
Twist Bioscience Corp
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2020Q3 twst Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
7506000
CY2020Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
290002000
CY2019Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
138107000
CY2020Q4 twst Net Exercise Of Common Stock Warrants Shares
NetExerciseOfCommonStockWarrantsShares
16051000
CY2020Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
7531000
CY2020Q4 twst Net Exercise Of Common Stock Warrants Shares
NetExerciseOfCommonStockWarrantsShares
6041000
CY2019 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
3200000
CY2018 us-gaap Related Party Transaction Purchases From Related Party
RelatedPartyTransactionPurchasesFromRelatedParty
2300000
CY2020 us-gaap Related Party Transaction Description Of Transaction
RelatedPartyTransactionDescriptionOfTransaction
During the years ended September 30, 2020, 2019, and 2018, the Company purchased raw materials from a related party investor in the amount of $3.4 million, $3.2 million, and $2.3 million, respectively. Payable balances and cash receipts and receivable balances with the related party were immaterial as of September 30, 2020, 2019, and 2018.
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
6915000
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
31246000
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6409000
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
7900000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
9000000
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.070
CY2019 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
4900000
CY2018 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
2500000
CY2019Q3 us-gaap Prepaid Rent
PrepaidRent
1600000
CY2019Q3 us-gaap Deferred Rent Credit
DeferredRentCredit
0
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y6M
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.24
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.25
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.22
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.04
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.01
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.01
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.01
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.28
CY2018 us-gaap Effective Income Tax Rate Reconciliation Deductions Other
EffectiveIncomeTaxRateReconciliationDeductionsOther
-0.01
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
6433000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
6568000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
7111000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
6753000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
6389000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
4907000
CY2020Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
38161000
CY2020 twst Common Stock Warrants Issued During The Period
CommonStockWarrantsIssuedDuringThePeriod
0
CY2019 twst Common Stock Warrants Issued During The Period
CommonStockWarrantsIssuedDuringThePeriod
0
CY2020Q3 twst Cash And Cash Equivalents And Short Term Investments Amortized Cost
CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost
289987000
CY2019Q3 twst Cash And Cash Equivalents And Short Term Investments Amortized Cost
CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost
138058000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.03
CY2020Q4 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
6041000
CY2020Q4 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
16051000
CY2019Q3 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
12019000
CY2019Q3 twst Common Stock Issued For Cashless Exercise
CommonStockIssuedForCashlessExercise
25422000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2018Q4 twst Net Exercise Of Common Stock Warrants Shares
NetExerciseOfCommonStockWarrantsShares
57122000
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45152511

Files In Submission

Name View Source Status
0001193125-20-303904-index-headers.html Edgar Link pending
0001193125-20-303904-index.html Edgar Link pending
0001193125-20-303904.txt Edgar Link pending
0001193125-20-303904-xbrl.zip Edgar Link pending
d92559d10k.htm Edgar Link pending
d92559dex211.htm Edgar Link pending
d92559dex231.htm Edgar Link pending
d92559dex311.htm Edgar Link pending
d92559dex312.htm Edgar Link pending
d92559dex321.htm Edgar Link pending
d92559dex322.htm Edgar Link pending
d92559dex45.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g92559g11a11.jpg Edgar Link pending
g92559g11a12.jpg Edgar Link pending
g92559g11a13.jpg Edgar Link pending
g92559g11a14.jpg Edgar Link pending
g92559g11a15.jpg Edgar Link pending
g92559g15s46.jpg Edgar Link pending
g92559g16v82.jpg Edgar Link pending
g92559g25j28.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
twst-20200930.xml Edgar Link completed
twst-20200930.xsd Edgar Link pending
twst-20200930_cal.xml Edgar Link unprocessable
twst-20200930_def.xml Edgar Link unprocessable
twst-20200930_lab.xml Edgar Link unprocessable
twst-20200930_pre.xml Edgar Link unprocessable